glp 1 agonist weight loss comparison GLP-1 Agonists for Loss: A Side-by-Side Changes in weight with GLP-1

However, the extent to which these benefits are truly independent of weight loss may differ by condition, and more research is needed to clarify these relationships

Wegovy B

A body mass index (BMI) over 25 is considered overweight, and over 30 is obese. According to the WHO the rate of obesity worldwide doubled in adults and quadrupled in adolescents between 1990 and 2022

The long-acting compounds have insulinotropic and glucagonostatic actions, and exert their main effect on fasting glucose levels [27-29]

[DOI] [PMC free article] [PubMed] [Google Scholar] 837.Gejl M., Brock B., Egefjord L., Vang K., Rungby J., Gjedde A